Lyophilization USA 2017
In-Person Event
Nov 16 - 17, 2017
Iselin, New Jersey, USA
OVERVIEW
Lyophilization USA is organized by SMi Group and would be held during Nov 16 - 17, 2017 at Renaissance Woodbridge Hotel, Iselin, New Jersey, United States Of America.
The target audience for this medical event for VPs, Directors, Chiefs, Heads, Principals, Managers and Analysts of:
• Freeze-drying/ Lyophilisation
• Formulation Scientist
• Bioprocessing
• Process Development
• Sterile/ Fill-Finish
• Production
• PAT
• CMC
• Chemistry
• Manufacturing
• Quality Assurance/QA
As biopharmaceuticals continue to dominate the market, the need for greater shelf life and protein stability has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing.
One of the main challenges in pharmaceutical lyophilization, continues to be the scale - up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines, protein and cells while also reducing costs.
Lyophilization USA will gather scientific leaders and drug manufacturers to discuss the latest cutting edge developments in freeze drying, as well as solutions to on-going industry challenges.
Key Topics Addressed:
• The impact of controlled nucleation on product quality and the technology being used for controlled ice nucleation.
• Examining the development and scale up of a freeze-drying cycle for biotherapeutics.
• Highlighting the approaches to effective holistic packaging and innovative design.
• Future developments in continuous manufacturing.
Featured Speakers:
• Lokesh Kumar, Associated Scientist, Genentech
• Charlie Tang, Associate Director, Formulation Development, Regeneron Pharmaceuticals
• Guido Schmitz, Global Head of Packaging & Technology Innovation, Bayer Consumer Care
• Perceval Sondag, Principal Statistician, Arlenda
• Eric Munson, Professor, Pharmaceutical Sciences, University of Kentucky
• Kelly Forney Stevens, Drug Product Development, GSK Vaccines
• Melissa Lash, Scientist, Large Molecule Drug Development, Johnson & Johnson
For those looking to attend, early bird rates are available online.
Price:
Conference 2 Workshops: USD 2897
Conference 1 Workshop: USD 2398
Conference Only: USD 1899
The target audience for this medical event for VPs, Directors, Chiefs, Heads, Principals, Managers and Analysts of:
• Freeze-drying/ Lyophilisation
• Formulation Scientist
• Bioprocessing
• Process Development
• Sterile/ Fill-Finish
• Production
• PAT
• CMC
• Chemistry
• Manufacturing
• Quality Assurance/QA
As biopharmaceuticals continue to dominate the market, the need for greater shelf life and protein stability has increased. For many biological products lyophilization is a necessity and the technology is constantly advancing.
One of the main challenges in pharmaceutical lyophilization, continues to be the scale - up and the implementation of QbD protocols for the optimization of cycles. Several companies are researching and developing ways to facilitate commercial bulk lyophilization of vaccines, protein and cells while also reducing costs.
Lyophilization USA will gather scientific leaders and drug manufacturers to discuss the latest cutting edge developments in freeze drying, as well as solutions to on-going industry challenges.
Key Topics Addressed:
• The impact of controlled nucleation on product quality and the technology being used for controlled ice nucleation.
• Examining the development and scale up of a freeze-drying cycle for biotherapeutics.
• Highlighting the approaches to effective holistic packaging and innovative design.
• Future developments in continuous manufacturing.
Featured Speakers:
• Lokesh Kumar, Associated Scientist, Genentech
• Charlie Tang, Associate Director, Formulation Development, Regeneron Pharmaceuticals
• Guido Schmitz, Global Head of Packaging & Technology Innovation, Bayer Consumer Care
• Perceval Sondag, Principal Statistician, Arlenda
• Eric Munson, Professor, Pharmaceutical Sciences, University of Kentucky
• Kelly Forney Stevens, Drug Product Development, GSK Vaccines
• Melissa Lash, Scientist, Large Molecule Drug Development, Johnson & Johnson
For those looking to attend, early bird rates are available online.
Price:
Conference 2 Workshops: USD 2897
Conference 1 Workshop: USD 2398
Conference Only: USD 1899
KEY DATES
16 Nov, 2017
Event Start Date
17 Nov, 2017
Event End Date
SPEAKERS
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
Renaissance Woodbridge HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links